Budget vs premium
Embody vs Start Willow: Which Costs Less Over 12 Months? (2026)
Compare Embody and Start Willow on real cost over 12 months, medication type, price stability and support. Independent 2026 analysis, no first-month gimmicks.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.6 and 7.3 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Both Embody and Start Willow will get a GLP-1 prescription to your door without an in-person visit. The question is what the year after that first shipment looks like.
On the number that matters after the first month, they are not close: Embody runs $69/mo against $299/mo at Start Willow — 4.3x more, every month, for the same drug class.
This comparison works from what each provider publishes: the entry price, what it becomes at month two, the medication actually dispensed, and what is bundled rather than billed. Anything a provider declines to disclose is marked undisclosed rather than filled in.
The short answer
- Lowest 12-month cost
- Embody — $828 against $3,538 at Start Willow, on each provider's own best published pricing.
- Most support for the money
- Start Willow — Direct-pay model that bypasses insurance pre-authorization.
- Fastest route to a first shipment
- Start Willow — Fully online, no in-person visits, then delivery guaranteed in 3 days or less.
- Most support included
- Start Willow — Direct-pay model that bypasses insurance pre-authorization.
Embody vs Start Willow: the specification
Nothing in this table is our estimate. Where a provider does not publish something, the cell says so.
| Embody | Start Willow | |
|---|---|---|
| Advertised price | Semaglutide $69/mo (was $299), tirzepatide $119/mo | From $249 the first month, then $299/mo |
| Rate after promotions | $69/mo | $299/mo |
| Pricing structure | Published rate per medication | Promotional first month, then standard rate |
| Medication | Compounded semaglutide and compounded tirzepatide | Compounded semaglutide and compounded tirzepatide |
| Shipping | Free shipping, 1-2 day delivery after approval | Delivery guaranteed in 3 days or less |
| Support model | No coaching program stated | No coaching program stated |
| Tirzepatide | $119/mo | Available |
| Price transparency | Published upfront | Published upfront |
| Patient reviews | 11,250 | 6,385 |
| eRxDoctor score | 7.6/10 | 7.3/10 |
What you will have spent by month twelve
The advertised rate answers the wrong question. What matters is the total at the point most people are still in treatment, so both programs are extended to six and twelve months below.
| Embody | Start Willow | |
|---|---|---|
| First month | $69 | $249 |
| Months 2 onward | $69/mo | $299/mo |
| 6-month total | $414 | $1,744 |
| 12-month total | $828 | $3,538 |
| Best published plan | No multi-month discount published | No multi-month discount published |
Embody finishes the year $2,710 cheaper. For some patients the support Start Willow bundles closes that gap; for a patient who only needs the prescription written, it does not.
Price escalation to plan for: Start Willow moves from $249 to $299, a 20% increase. Set a calendar reminder for the month it changes.
What the price difference actually buys
The gap runs to 4.3x a month. What Start Willow offers for it: direct-pay model that bypasses insurance pre-authorization, plus delivery guaranteed in 3 days or less.
On the other side, Embody leads with the lowest published semaglutide price on this list, with no lock-in — with one qualification: a limited-time rate with few of the extras that higher-priced platforms bundle.
Price gaps in this market rarely reflect a different molecule; they reflect a different amount of human contact. Decide how much of that you actually intend to use before paying for it.
How Embody works
Semaglutide $69/mo (was $299), Tirzepatide $119/mo Against Start Willow, that puts it in the position of the cheaper option.
The process is licensed provider review handled entirely online, then free shipping, 1-2 day delivery after approval. On money, expect published rate per medication — published upfront.
What continues after the first shipment: 24/7 support for dosing and side-effect questions. Formulary: compounded semaglutide and compounded tirzepatide.
Embody pros
- Licensed provider review handled entirely online
- Compounded tirzepatide available at $119/month
- Lowest entry price on this list at $69/month for compounded semaglutide
- No long-term commitment; cancel without penalty
Embody cons
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- Fewer premium features (no integrated coaching or advanced monitoring) than higher-priced platforms
- Final pricing may vary based on dose and clinician recommendation
Set beside Start Willow, the thing to weigh: a limited-time rate with few of the extras that higher-priced platforms bundle.
Inside the Start Willow program
From $249 per Month What it is really selling here is a delivery guarantee of three days or less and no membership stacked on the medication price.
Getting started means fully online, no in-person visits, after which delivery guaranteed in 3 days or less. Pricing runs on a promotional first month, then standard rate basis, published upfront.
Direct-pay model that bypasses insurance pre-authorization. The formulary covers compounded semaglutide and compounded tirzepatide.
Start Willow pros
- No insurance needed and no membership fees
- Medications comparable to Ozempic and tirzepatide
- Delivery guaranteed in 3 days or less
- Direct-pay model bypasses insurance pre-authorization entirely
Start Willow cons
- Ongoing $299/month is among the higher rates on this list
- Price rises from $249 first month to $299/month ongoing
- Compounded medication only, no branded Ozempic or Wegovy
Where it gives ground to Embody: at $299 ongoing it is among the most expensive compounded programs here.
Which one fits which patient
Choose Embody if:
- the twelve-month total is what you are optimizing ($828 against $3,538)
- the monthly rate is the constraint — $69/mo against $299/mo
- the level of clinical contact suits you: 24/7 support for dosing and side-effect questions
- what it leads on is worth paying for in your case: the lowest published semaglutide price on this list, with no lock-in
Choose Start Willow if:
- the feature you would actually use: a delivery guarantee of three days or less and no membership stacked on the medication price
- the level of clinical contact suits you: direct-pay model that bypasses insurance pre-authorization
- you want to start on their timeline: fully online, no in-person visits
- delivery works the way you want it to: delivery guaranteed in 3 days or less
Where each program concedes something
On price. The monthly gap is 4.3x in Embody's favor. Whether that is a saving or a false economy turns on one thing: a limited-time rate with few of the extras that higher-priced platforms bundle.
On predictability. Published rate per medication at Embody, against promotional first month, then standard rate at Start Willow. The more predictable structure is worth a premium to anyone who has been surprised by a telehealth invoice before.
On access. Embody advertises licensed provider review handled entirely online and free shipping, 1-2 day delivery after approval; Start Willow advertises fully online, no in-person visits and delivery guaranteed in 3 days or less. Neither publishes its state coverage, so confirm you are eligible before paying for anything.
On medication. Embody covers compounded semaglutide and compounded tirzepatide; Start Willow covers compounded semaglutide and compounded tirzepatide. Neither locks you out of a molecule the other offers, so this is unlikely to be the deciding factor.
The clinical evidence, separated from the marketing
Weight loss percentages quoted in telehealth marketing come from trials neither Embody nor Start Willow ran. Here is the source material, and what regulators say alongside it.
NIDDK frames medication as one component of obesity treatment rather than a replacement for the rest of it, per NIH, NIDDK.
Compounded drugs are not FDA-approved, and the agency does not verify their safety, effectiveness or quality before they reach a patient, per FDA.
Which is to say: the medication decision belongs with a clinician, and the platform decision belongs with a spreadsheet.
Embody vs Start Willow: common questions
Which is cheaper to start, Embody or Start Willow?
Embody, at $69 against $249. Note that the cheapest first month and the cheapest year are often different providers here — check the 12-month row of the cost table before deciding on the entry price.
Which costs less over a year, Embody or Start Willow?
Embody, at roughly $828 for twelve months against $3,538 at Start Willow, using each provider's own best published pricing. Those totals cover medication and program fees as published; they exclude anything a provider bills separately, and they assume you stay on the same plan for the full year.
Is Embody cheaper than Start Willow?
Yes, on the ongoing rate. Embody runs $69/mo once promotional pricing ends, against $299/mo at Start Willow — a difference of 4.3x. Compare the first-month offers separately, because both providers discount entry differently from the rate you will actually be paying by month three.
What happens if I stop taking the medication?
Neither Embody nor Start Willow penalizes you for stopping, but the medication does. The published follow-up data on withdrawal shows substantial regain, which is why the twelve-month totals above matter more than either provider's introductory offer.
Is Embody or Start Willow better for a first GLP-1 prescription?
First-timers usually get more from clinical access than from a lower rate, because the first two months are where most people stop. On that basis Embody has the stronger case; after month three, cost should take over.
Are Embody and Start Willow legitimate?
Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. Embody operates on published rate per medication with pricing published upfront, Start Willow on promotional first month, then standard rate, published upfront. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.
The verdict
On the numbers, Embody wins the year: $828 against $3,538. That is the default answer, and it is the right one for anyone who mainly needs a reliable prescription and a shipment that arrives.
Start Willow earns the difference in one situation: when a delivery guarantee of three days or less and no membership stacked on the medication price is something you will genuinely use. If you cannot say that out loud, take the cheaper program.
Both platforms are legitimate routes to a GLP-1 prescription. The decision is commercial, and it should be made with the twelve-month figure in front of you rather than the first-month one.
Keep comparing
- Embody vs WellorithmPublished price vs quote-only
- Refills vs EmbodyBudget vs premium
- Directmeds vs Start WillowPublished price vs quote-only
- Enhance MD vs Start WillowBudget vs premium
- Yucca Health vs EmbodyBudget vs premium
- altRx vs Sprout HealthBudget vs premium
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Embody or Start Willow, and does not sell treatment. Read our ranking methodology.